Literature DB >> 18308811

Diphenhydramine abuse and detoxification: a brief review and case report.

A Thomas1, D G Nallur, N Jones, P N Deslandes.   

Abstract

Many medicines available over the counter from pharmacies are known to have abuse potential, including diphenhydramine (DPH), an antihistamine with antimuscarinic properties used for the treatment of insomnia. We present a brief review of the literature describing DPH abuse, and report the case of GF, a 56 year old woman who was admitted to an inpatient addictions unit for detoxification from DPH. A literature search revealed five case reports of DPH abuse including a total of six patients, published between 1986 and 2001. All reported cases exhibited features of DSM-IV criteria for substance dependence, and there was an apparent link with antipsychotic usage. GF was treated with antipsychotics, and was using up to thirty 50 mg DPH tablets each day. She described feeling 'good and calm' and 'it stopped the tremors'. GF tolerated a gradual dose reduction schedule, and completed the detoxification programme relatively comfortably. She was discharged from the inpatient detoxification unit as planned, and had not relapsed at six months. The described case report highlights the importance of enquiring about non prescribed medication when taking a drug history. Similarly community pharmacists and GPs should be vigilant to excessive requests for DPH, particularly in patients with a psychotic illness.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18308811     DOI: 10.1177/0269881107083809

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  9 in total

1.  The importance of taking a history of over-the-counter medication use: a brief review and case illustration of "PRN" antihistamine dependence in a hospitalized adolescent.

Authors:  Barbara Gracious; Naomi Abe; Jane Sundberg
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-12       Impact factor: 2.576

2.  Chronic diphenhydramine abuse and withdrawal: A diagnostic challenge.

Authors:  Jagroop S Saran; Richard L Barbano; Rachel Schult; Timothy J Wiegand; Olga Selioutski
Journal:  Neurol Clin Pract       Date:  2017-10

3.  How do pharmacists respond to complaints of acute insomnia? A simulated patient study.

Authors:  Carly Kippist; Keith Wong; Delwyn Bartlett; Bandana Saini
Journal:  Int J Clin Pharm       Date:  2011-03-12

Review 4.  Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond.

Authors:  Sarah C Glover; Melody C Carter; Peter Korošec; Patrizia Bonadonna; Lawrence B Schwartz; Joshua D Milner; George H Caughey; Dean D Metcalfe; Jonathan J Lyons
Journal:  Ann Allergy Asthma Immunol       Date:  2021-08-13       Impact factor: 6.248

5.  Behavioral and neurochemical effects of cocaine and diphenhydramine combinations in rhesus monkeys.

Authors:  Matthew L Banks; Monica L Andersen; Kevin S Murnane; Rebecca C Meyer; Leonard L Howell
Journal:  Psychopharmacology (Berl)       Date:  2009-05-09       Impact factor: 4.530

6.  Evaluation of the Reinforcing Effect of Quetiapine, Alone and in Combination with Cocaine, in Rhesus Monkeys.

Authors:  Robert E Brutcher; Susan H Nader; Michael A Nader
Journal:  J Pharmacol Exp Ther       Date:  2015-12-07       Impact factor: 4.030

Review 7.  When good times go bad: managing 'legal high' complications in the emergency department.

Authors:  Charles R Caffrey; Patrick M Lank
Journal:  Open Access Emerg Med       Date:  2017-12-20

8.  Misuse and dependence on non-prescription codeine analgesics or sedative H1 antihistamines by adults: a cross-sectional investigation in France.

Authors:  Anne Roussin; Annabelle Bouyssi; Lucie Pouché; Laure Pourcel; Maryse Lapeyre-Mestre
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

9.  Beyond the 'purple drank': Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports.

Authors:  Stefania Chiappini; Fabrizio Schifano; John Martin Corkery; Amira Guirguis
Journal:  J Psychopharmacol       Date:  2021-01-10       Impact factor: 4.153

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.